Hzymes (Fujian)Biotechnology Co., Ltd. officially inaugurated
On June 23, 2022, the inauguration ceremony of Hzymes (Fujian) Biotechnology Co., Ltd. was held in the National University Science and Technology Park of Fuzhou University. The company management was attend the ceremony, included Dr. Yang Guangyu, founder and chairman of Hzymes biotech, Director Mr.Chen Xilin, Co-founder Mr. Zhang Rongcai, general manager of Fujian Company, Mr. Qian Hongyun of Marketing Department, etc. Professor Huang Jianzhong, director of the Engineering Center of Industrial Microbiology and Education Of Fujian Normal University, Professor Lin Juan and Professor Meng Chun of the School of Biological Engineering of Fuzhou University, Professor Xu Peng of the National and Local Joint Engineering Research Center for Biopharmaceutical Photodynamic Therapy Technology of Fuzhou University and other guests and friends were also invited to the ceremony.
Ceremony
At 11:00 a.m., the ceremony officially began, And Professor Yang Guangyu, chairman of the board, delivered a speech on behalf of the company, expressed his appreciation to the colleagues who have been concern and supported the development of the company, expressed a warm welcome to the guests and friends who came to the ceremony, and encouraged all employees to fulfill their duties, unite and forge ahead, seize opportunities, meet challenges, and strive to achieve the company’s strategic goals. We also hope to strengthen cooperation with partners, complement each other’s advantages, create a win-win situation, and contribute to the benign development of the pharmaceutical industry. Subsequently, under the witness of the guests, Chairman Professor Yang Guangyu and Mr. Zhang Rongcai, General Manager of Fujian Company, jointly unveiled the new company, and in the warm applause, Hzymes (Fujian) Biotechnology Co., Ltd. was officially announced.
After the ceremony, Dr. Yang Guangyu delivered a report entitled “Targeted Creation and Application of Biomedical Special Enzyme Preparations”, the epidemic has promoted the rapid development of in vitro diagnosis, coupled with the help of capital, the IVD industry has ushered in the spring of development. As one of the core raw materials for in vitro diagnostics, enzyme have three major difficulties in research and development and production:
- The mining and transformation of key enzyme functions,
- The large-scale fermentation of host microorganisms,
- The study of the adaptability of enzyme preparations and detection systems.
Professor Yang also summarized the experience from refined R&D to scale manufacturing from the four key technologies of enzyme function mining and transformation, and took the development of anti-hydroxyhydrin detection reagents and ring-mediated isothermal amplification reaction (LAMP) reagents as examples.
Professor Huang Jianzhong
Director of the Engineering Center.
Ministry of Industrial Microbiology, Fujian Normal University
Professor Lin Juan
School of Biological Engineering, Fuzhou University.
Professor Meng Chun
School of Biological Engineering, Fuzhou University
Hzymes (Fujian) Biotechnology Co., Ltd. is a subsidiary of Hzymes Biotech Group, Hzymes aspires to become “the world’s first-class special enzyme products and services provider”, the global biological industry core raw material supply safety as corporate responsibility, has made remarkable achievements, won widespread trust and respect. Hzymes, with rich experience in industry operation, mature sales network layout and elite business team and strong scientific research and development technology team, is a high-tech enterprise integrating biopharmaceutical raw materials, vaccine preparation raw materials, in vitro diagnostic raw materials research and development, production and service. The company has two original technology platforms such as microfluidic ultra-high-throughput screening and artificial intelligence enzyme molecular structure design, reaching the world’s first-class enzyme development and application technology level.
Group photo
With the continuous changes in the market environment, in order to meet the needs of market development, so that enterprises continue to maintain success and make breakthroughs in the future, and integrate superior resources, Hzymes biotech has set up R&D and production centers in Shanghai, Wuhan, Suzhou, Qingdao, Yichang and other five places. Today, Hzymes (Fujian) Biotechnology Co., Ltd. has been established. Hzymes has been adhering to the construction of a world-class special enzyme creation platform. On the road to the future, Hzymes (Fujian) Biotechnology Co., Ltd. relies on the powerful platform and resources of Hzymes Biotech Group, and all employees are united in their will to create a better future and strive to achieve corporate goals and values!